Unknown

Dataset Information

0

LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis.


ABSTRACT:

Background

The incidence and mortality of thyroid cancer (TC) has been steadily rising in the past decades. It is imperative to have a better understanding of the molecular mechanisms underlying TC development and identify novel therapeutic targets. This study characterized the role of lncRNA CALML3-AS1 (CALML3-AS1) in the development of papillary thyroid cancer (PTC).

Method

Related mRNAs expression were validated in the tumor and adjacent normal tissues from 52 PTC patients and PTC cell lines by qRT-PCR. Expression of RBM38 was detected by Western blot. We have also conducted CCK-8 and colony formation assays were used to detect the effect of CALML3-AS1 on cell proliferation, Transwell assay was utilized to evaluate cell migration and invasion, apoptosis detected by flow cytometry assay, RNA pull-down and luciferase assays were performed to validate gene predictions.

Results

The results indicated that the expression of both CALML3A-S1 and RBM38 were significantly downregulated in PTC tissues (p < 0.01), while the expression of miR-20a-5p was increased in PTC (p < 0.01). Functionally, CALML3-AS1 overexpression inhibited PTC cell proliferation in vitro and in vivo. Mechanistically, CALML 3-AS1 sponged miR-20a-5p, which in turn leads to the suppression of RBM38 expression and PTC progression.

Conclusions

CALML3-AS1 functions as a ceRNA for miR-20a-5p in the regulation of the expression of RBM38 in PTC. Higher level of CALML3-AS1 serves as a good prognostic indicator of survival in PTC patients. Targeting CALML3-AS1/ miR-20a-5p/RBM38 axis may represent a novel therapeutic strategy in the treatment of PTC.

SUBMITTER: Zhang X 

PROVIDER: S-EPMC8966157 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis.

Zhang Xiaozhou X   Zhang Xiaojian X   Jia Qian Q   Li Hongqiang H   Ma Runsheng R   Yang Guang G   Yin Fengyan F   Jiang Nannan N   Yin Detao D  

BMC cancer 20220329 1


<h4>Background</h4>The incidence and mortality of thyroid cancer (TC) has been steadily rising in the past decades. It is imperative to have a better understanding of the molecular mechanisms underlying TC development and identify novel therapeutic targets. This study characterized the role of lncRNA CALML3-AS1 (CALML3-AS1) in the development of papillary thyroid cancer (PTC).<h4>Method</h4>Related mRNAs expression were validated in the tumor and adjacent normal tissues from 52 PTC patients and  ...[more]

Similar Datasets

| S-EPMC10259264 | biostudies-literature
| S-EPMC7373409 | biostudies-literature
| S-EPMC7874083 | biostudies-literature
| S-EPMC5525075 | biostudies-other
| S-EPMC7655169 | biostudies-literature
| S-EPMC10562957 | biostudies-literature
| S-EPMC10775490 | biostudies-literature
| S-EPMC10719255 | biostudies-literature
| S-EPMC8312431 | biostudies-literature
| S-EPMC7245777 | biostudies-literature